US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MRBL Enhanced Equity ETF

36.53

+0.23700.65%

Volume:409.00

Turnover:14.92K

Market Cap:1.15B

PE:- -

High:36.53

Open:36.43

Low:36.43

Close:36.29

Loading ...

Overview Company News Filings

Company Profile

Company Name:

MRBL Enhanced Equity ETF

Exchange:

CBOE

Establishment Date:

- -

Employees:

- -

Office Location:

19 East Eagle Road,Havertown,Pennsylvania,United States

Website:

http://www.edgetherapeutics.com

Zip Code:

19083

Phone:

Fax:

216 245 3686

Introduction:

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EDGE/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EDGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDGE\",,,,,undefined,":{"symbol":"EDGE","market":"US","secType":"STK","nameCN":"MRBL Enhanced Equity ETF","latestPrice":36.5311,"timestamp":1745611200000,"preClose":36.2941,"halted":0,"volume":409,"delay":0,"floatShares":140000,"shares":31509822,"eps":0,"marketStatus":"Pre-Mkt","change":0.237,"latestTime":"04-28 06:47:20 EDT","open":36.43,"high":36.5311,"low":36.43,"amount":14921.9257,"amplitude":0.002786,"askPrice":58.44,"askSize":200,"bidPrice":14.62,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745847000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":36.5311,"sharesOutstanding":140000,"nav":36.24,"aum":5073600,"bidAskSpread":0,"volumeRatio":0.4190573942236637},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDGE\",,,,,undefined,":{"symbol":"EDGE","floatShares":140000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.4190573942236637,"shares":31509822,"dividePrice":0,"high":36.5311,"amplitude":0.002786,"preClose":36.2941,"low":36.43,"week52Low":31.99,"pbRate":"--","week52High":40.97,"institutionHeld":0,"latestPrice":36.5311,"eps":0,"divideRate":0,"volume":409,"delay":0,"ttmEps":0,"open":36.43,"prevYearClose":40.2,"prevWeekClose":36.5311,"prevMonthClose":37.1848,"prevQuarterClose":37.1848,"fiveDayClose":35.7202,"twentyDayClose":37.995,"sixtyDayClose":39.976},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1902083742,"address":"19 East Eagle Road,Havertown,Pennsylvania,United States","zipCode":"19083","officePhone":"215 882 9983","officeFax":"216 245 3686"},"stockCompanyDetail":{"websiteUrl":"http://www.edgetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0227},{"period":"1month","weight":-0.0385},{"period":"3month","weight":-0.0944},{"period":"6month","weight":-0.0913},{"period":"ytd","weight":-0.0913}],"compareEarnings":[{"period":"1week","weight":0.046},{"period":"1month","weight":-0.0316},{"period":"3month","weight":-0.0943},{"period":"6month","weight":-0.049},{"period":"1year","weight":0.0936},{"period":"ytd","weight":-0.0605}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.","exchange":"CBOE","name":"MRBL Enhanced Equity ETF","nameEN":"MRBL Enhanced Equity ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EDGE\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDGE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDGE\",market:\"US\",delay:false,,,undefined,":{}}}